Moderna’s CEO Stéphane Bancel spoke at the Boston College Chief Executives Club on April 5. While COVID-19 vaccine production was a big talking point for the leader of Moderna, he also touched on how mRNA technology can usher us into a longer life span, saying that he tells all of his friends to “not die” in the next ten years.

The U.S. Food and Drug Administration approved the first test – a diagnostic from Meridian Bioscience Inc. – to help detect a type of herpes virus in newborns.

Merck & Co. Ltd.’s drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. FDA.

An experimental Merck drug succeeded in preventing clinically serious cytomegalovirus following bone marrow transplant and was associated with a lower death rate compared with placebo.

Merck & Co.’s experimental drug to prevent cytomegalovirus infection in high-risk bone marrow transplant patients met its primary goal in late-stage trial.